KP-100IT

· Kringle Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KP-100IT, covering 2019-06-05 to 2022-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury [Phase 3]